Software Code for paper on codonGPT and codonGPT-RL by Anuj Guruacharya (22332988)

Subjects:

Software Code for paper on codonGPT and codonGPT-RL by Anuj Guruacharya (22332988)

Subjects:

Table 1_A novel multi-epitope mRNA vaccine against colorectal cancer: in silico design and immune efficacy profiling.docx by Lin Wang (11986)

Codon optimization maps for all of the multi-epitope vaccine constructs including MEVC1, MEVC2, MEVC3, MEVC4 and MEVCWP. by Habiba Naz (20685373)

Subjects:

The constructed vaccine was validated using I-TASSER in a model. by Ahmad Abdullah Mahdeen (19704401)

The structural validation of the final vaccine construct by SAVES, ProSA, and SWISS-MODEL structure assessment server. by Rehana Parvin (841451)

3° model showing the conformational B-cell epitopes of the vaccine design. by Ahmad Abdullah Mahdeen (19704401)

<b>Constraint-Based Analysis Reveals Inevitable </b><b>Mathematical Structure in the Genetic Code</b> by Bernhard Pfennigschmidt (22044887)

“…Experimental evidence from bacterial codon usage patterns supports the model's prediction that "synonymous" codons possess distinct molecular properties. …”

The assembly of a multiepitope vaccine targeting HeV and the ribbon 3° model of the vaccine. by Ahmad Abdullah Mahdeen (19704401)

Additional file 2 of Preclinical evaluation of AAV9-coSMN1 gene therapy for spinal muscular atrophy: efficacy and safety in mouse models and non-human primates by Wenhao Ma (14935772)

Subjects:

Additional file 1 of Preclinical evaluation of AAV9-coSMN1 gene therapy for spinal muscular atrophy: efficacy and safety in mouse models and non-human primates by Wenhao Ma (14935772)

Subjects:

In silico cloning of the Gag vaccine construct A1) pET-30a(+) plasmid and A2) pcDNA3.1(+) vector. by Ava Hashempour (11753878)

Subjects:

Percentage of combined (MHC I and MHC II) coverage of the selected epitopes (CTL and HTL) of the Gag vaccine in the global population (Generated by https://certmapper.cr.usgs.gov/d... by Ava Hashempour (11753878)

Subjects:

Discontinuous B-cell epitopes on the vaccine construct (1–6) are indicated by the orange region of the Gag vaccine, which depicts each discontinuous B-cell epitope comprising resid... by Ava Hashempour (11753878)

Subjects:

Potential antigenic and immunogenic CTL epitopes. by Ava Hashempour (11753878)

Subjects:

A list of BCL-selected epitopes of the Gag vaccine. by Ava Hashempour (11753878)

Subjects:

Immune simulation outcomes obtained from C-IMMSIM after administration of the Gag vaccine are shown in plots a-j. by Ava Hashempour (11753878)

Subjects:

Fig 6 - by Ava Hashempour (11753878)

Subjects:

Flowchart of Gag vaccine design in this research. by Ava Hashempour (11753878)

Subjects:

Discontinuous epitopes found in the Gag vaccine construct overlap with linear epitopes. by Ava Hashempour (11753878)

Subjects: